Stock Price Quote

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC
BSE5161.05-75.15 (-1.44 %)
PREV CLOSE ( ) 5236.20
OPEN PRICE ( ) 5200.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 314
TODAY'S LOW / HIGH ( )5141.30 5222.05
52 WK LOW / HIGH ( )4640.3 5835.95
NSE5168.50-55 (-1.05 %)
PREV CLOSE( ) 5223.50
OPEN PRICE ( ) 5240.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 5168.50 (12)
VOLUME 16249
TODAY'S LOW / HIGH( ) 5160.50 5240.00
52 WK LOW / HIGH ( )4636.55 5850
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-04 1967
Management Info
Suresh N Talwar - Chairman Milind Thatte - Managing Director
Registered Office

Address Ground Floor And First Floor P & G Plaza,Cardinal Gracias Road,Chakala, Andheri (East),
Mumbai,
Maharashtra-400099

Phone 022 68669000

Email investorgrievance.im@pg.com

Website www.pghealthindia.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

10Mar Procter & Gamble Health informs about
Procter & Gamble Health has submitted the notice of the Postal Ballo..
18Feb Procter & Gamble Health informs about
Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated..
12Feb Procter & Gamble Health reports 26% ri
Procter & Gamble Health has reported results for quarter ended Decem..
21Dec Procter & Gamble Health informs about
Procter & Gamble Health has been informed by its Registrars and Shar..
07Dec Procter & Gamble Health informs about
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit9092009.8
Gross Profit 1216.9 2733.2
Operating Profit 1273.93216.3
Net Sales 3097.711512.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
peergroup  8942.35 (2.41%)
M.Cap ( in Cr)22137.50
RPG Life Sciences (BSE)
peergroup  2273.40 (4.41%)
M.Cap ( in Cr)3699.28
Sanofi India (BSE)
peergroup  6362.00 (0.88%)
M.Cap ( in Cr)14652.43
Pfizer (BSE)
peergroup  4244.00 (1.24%)
M.Cap ( in Cr)19392.46
Samrat Pharmachem (BSE)
peergroup  405.40 (12.50%)
M.Cap ( in Cr)125.44

Shareholding Pattern

PROMOTERS 51.82%
FI/BANKS/INSURANCE 3.77%
NON-INSTITUTION 26.46%
MUTUAL FUNDS/UTI 10.64%
GOVERNMENT 0%
FII 0%

About Procter & Gamble Health Ltd.

Procter & Gamble Health Ltd. was incorporated in the year 1967. Its today's share price is 5161.05. Its current market capitalisation stands at Rs 8590.18 Cr. In the latest quarter, company has reported Gross Sales of Rs. 12592.4 Cr and Total Income of Rs.11668.9 Cr. The company's management includes Zeal Rupani, Seema Sambasivan, Aalok Agrawal, Lokesh Chandak, Milind Thatte, S Madhavan, Rani Jadhav Ajit, Suresh N Talwar.

It is listed on the BSE with a BSE Code of 500126 , NSE with an NSE Symbol of PGHL and ISIN of INE199A01012. It's Registered office is at Ground Floor And First Floor P & G Plaza,Cardinal Gracias Road,Chakala, Andheri (East)Mumbai-400099, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co, BSR & Co LLP, Haribhakti & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.